Levine James E. 4
4 · Cardiff Oncology, Inc. · Filed Mar 10, 2022
Insider Transaction Report
Form 4
Levine James E.
Chief Financial Officer
Transactions
- Award
Stock Options
2022-03-09+170,016→ 560,016 totalExercise: $2.50Exp: 2032-03-09→ Common Stock (170,016 underlying)
Footnotes (1)
- [F1]42,504 vest on 3/09/2023. 3,542 vest monthly for 36 months beginning on 4/09/2023 through 3/09/2026.